TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26141535

Group type: EXPERIMENTAL
Intervention: Temperature-controlled continuous cold flow device (Hilotherm® group)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ice bag (control group)
Number of subjects: 47
Study: 24103530

Group type: EXPERIMENTAL
Intervention: Hands-on training (group 2)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Demonstration (group 1)
Number of subjects: 172
Study: 17148774

Group type: EXPERIMENTAL
Intervention: Doxorubicin and cyclophosphamide administered concurrently
Number of subjects: 2123

Group type: COMPARATOR
Intervention: Doxorubicin and cyclophosphamide administered sequentially
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Higher p27 expression
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Cyclin E expression
Number of subjects: 2123
Study: 12962749

Group type: COMPARATOR
Intervention: Induction therapy with polyclonal or monoclonal antilymphocytic antibodies associated with cyclosporine and prednisone (n=201)
Number of subjects: 379

Group type: COMPARATOR
Intervention: Cyclosporine, mycophenolate mofetil, and prednisone (n=127)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Tacrolimus, mycophenolate mofetil, and prednisone (n=51)
Number of subjects: 379
Study: 10078748

Group type: EXPERIMENTAL
Intervention: pimozide (n = 6)
Number of subjects: 10

Group type: COMPARATOR
Intervention: withdrawn from therapy (n = 4)
Number of subjects: 10
Study: 7732997

Group type: EXPERIMENTAL
Intervention: Intensive diabetes treatment
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional diabetes treatment
Number of subjects: 1441
Study: 1682228

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg + Amiloride 5 mg
Number of subjects: 165

Group type: COMPARATOR
Intervention: Diuretic group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Perindopril group
Number of subjects: 165
Study: 7124828

Group type: EXPERIMENTAL
Intervention: Variable practice
Number of subjects: 24

Group type: COMPARATOR
Intervention: Constant practice
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 24
Study: 31270896

Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Physical activity recommendation from the World Health Organization
Number of subjects: 80
Study: 30246560

Group type: EXPERIMENTAL
Intervention: Economic stress group (reading a news article about uncertain financial future)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (reading a news article about a tour of the Royal Canadian Mint)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Economic stress group
Number of subjects: 178
Study: 26984523

Group type: EXPERIMENTAL
Intervention: Facebook (n = 14)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Online diary website (active control, n = 13)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Waitlist (n = 14)
Number of subjects: 41
Study: 25744453

Group type: EXPERIMENTAL
Intervention: Orally disintegrating tablets (ODTs) with organoleptic masking (L-menthol, aspartame, thaumatin, cinnamon) and physical masking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Orally disintegrating tablets (ODTs) with physical masking
Number of subjects: 10

Group type: COMPARATOR
Intervention: Orally disintegrating tablets (ODTs) without organoleptic masking
Number of subjects: 10
Study: 22999568

Group type: COMPARATOR
Intervention: Metronome-paced walking
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Self-paced brisk walking
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Treadmill walking at 2.7 mph
Number of subjects: 25

Group type: COMPARATOR
Intervention: Metronome-guided moderate pace walking
Number of subjects: 25
Study: 21192769

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 325

Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 325
Study: 18678570

Group type: EXPERIMENTAL
Intervention: Customized vestibular rehabilitation for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: General instructions
Number of subjects: 53
Study: 16176314

Group type: EXPERIMENTAL
Intervention: Small caliber audio-Doppler probe (AU group, n = 42)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ultrasound scanner (US group, n = 39)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Both methods (audio-Doppler and ultrasound scanner)
Number of subjects: 81
Study: 12948713

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10841922

Group type: EXPERIMENTAL
Intervention: Glyceroltrinitrate (GTN; 0.4 mg/h)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyceroltrinitrate (GTN; 0.4 mg/h) + Vitamin C (Vit-C; 55 μg/kg/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin C (Vit-C; 55 μg/kg/min) alone
Number of subjects: 0
Study: 8905031

Group type: EXPERIMENTAL
Intervention: Conventional doses of L-asparaginase (L-ASE) 10,000 IU/sqm every three days during the induction phase (8 doses, first exposure)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Conventional or high doses of L-asparaginase (L-ASE) during the second or third exposures (high-dose L-ASE 25,000 IU/sqm weekly for a total of 20 doses)
Number of subjects: 54
Study: 2065789

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 285

Group type: COMPARATOR
Intervention: LH-timed intercourse
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI) for severe semen defect
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: First IUI cycle
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Overall IUI pregnancies
Number of subjects: 285
Study: 6125161

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Org NC 45
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 3
Study: 31411039

Group type: EXPERIMENTAL
Intervention: Apathy (defined by three items from Geriatric Depression Scale)
Number of subjects: 1679
Study: 30554923

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT, n = 6)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MOD, n = 5)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Wait-list Control (CON, n = 6)
Number of subjects: 17
Study: 28911991

Group type: EXPERIMENTAL
Intervention: Cataract surgery with concomitant prophylactic sclerostomy (sclerostomy group, n = 29)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cataract surgery alone (control group, n = 31)
Number of subjects: 60
Study: 27401184

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 667
Study: 25188655

Group type: EXPERIMENTAL
Intervention: Home-based training (rD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hospital outpatient training (rH)
Number of subjects: 50
Study: 22805300

Group type: EXPERIMENTAL
Intervention: 2 g fibrinogen concentrate
Number of subjects: 245

Group type: COMPARATOR
Intervention: 100 ml isotonic saline (placebo)
Number of subjects: 245
Study: 19250300

Group type: EXPERIMENTAL
Intervention: Nonablative fractional laser (NAFL) 1,550 nm
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL) 595 nm
Number of subjects: 12
Study: 16960847

Group type: EXPERIMENTAL
Intervention: Graded pairs comparison method for assessing preferences for specialized nurse home visits for pain management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ordered-response regression models using graded pairs data
Number of subjects: 0
Study: 14999613

Group type: EXPERIMENTAL
Intervention: Indinavir, lamivudine, and zidovudine
Number of subjects: 10
Study: 12051112

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen therapy (Menorest, 50 micrograms)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9797622

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Diamorphine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Both morphine and diamorphine
Number of subjects: 88
Study: 7618661

Group type: EXPERIMENTAL
Intervention: 51W89 besylate 0.1 mg.kg‐1
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 51W89 besylate 0.15 mg.kg‐1
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 51W89 besylate 0.2 mg.kg‐1
Number of subjects: 19

Group type: COMPARATOR
Intervention: Atracurium 0.5 mg.kg‐1
Number of subjects: 19

Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 19
Study: 2372674

Group type: EXPERIMENTAL
Intervention: Midnight catheter removal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early morning catheter removal
Number of subjects: 0
Study: 368703

Group type: EXPERIMENTAL
Intervention: Chlorprothixene 50 mg b.d. (twice daily) to outpatients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorprothixene 50 mg every 6 hours to inpatients for 5 days
Number of subjects: 0
Study: 31234864

Group type: EXPERIMENTAL
Intervention: Metacognitive Interpersonal Therapy (MIT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Structured Clinical Management (SCM)
Number of subjects: 80
Study: 28891826

Group type: EXPERIMENTAL
Intervention: 20 mL of 0.375% ropivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mL of 0.375% ropivacaine
Number of subjects: 0
Study: 25590323

Group type: EXPERIMENTAL
Intervention: Silicone stent
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Prolene (polypropylene) stent
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Otologic T‐tube stent
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 91

Group type: COMPARATOR
Intervention: Comparison between silicone and Prolene
Number of subjects: 91
Study: 24818429

Group type: EXPERIMENTAL
Intervention: On the Way Home (OTWH) aftercare program
Number of subjects: 82

Group type: COMPARATOR
Intervention: Traditional aftercare supports
Number of subjects: 82
Study: 21806387

Group type: EXPERIMENTAL
Intervention: CYP2C19 LOF alleles (specifically two LOF alleles)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: CYP2C19 genotypes (gene-dose effect)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: CYP2C19 LOF allele presence
Number of subjects: 189

Group type: COMPARATOR
Intervention: PON-1 and ABCB1 genotypes
Number of subjects: 189
Study: 19181226

Group type: EXPERIMENTAL
Intervention: Open carpal tunnel release
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 2-portal endoscopic carpal tunnel release
Number of subjects: 128
Study: 17098626

Group type: EXPERIMENTAL
Intervention: Epaxal (aluminium-free, virosome-adjuvanted vaccine)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Havrix (aluminium-adsorbed HAV vaccine)
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Epaxal
Number of subjects: 529

Group type: COMPARATOR
Intervention: Havrix
Number of subjects: 529
Study: 15517641

Group type: EXPERIMENTAL
Intervention: Corticosteroid (80 mg triamcinolone acetonide)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Local anesthetic (1% mepivacaine)
Number of subjects: 80
Study: 11273918

Group type: EXPERIMENTAL
Intervention: BIS guided (BIS)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard practice (SP)
Number of subjects: 202
Study: 9332238

Group type: EXPERIMENTAL
Intervention: alpha 1-antitrypsin augmentation therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 8466026

Group type: EXPERIMENTAL
Intervention: 5% albumin (n = 14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Isotonic crystalloid (n = 14)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 31
Study: 2879477

Group type: EXPERIMENTAL
Intervention: tertatolol 5 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: acebutolol 400 mg
Number of subjects: 32
Study: 29331635

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg sotatercept
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg sotatercept
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg sotatercept
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg sotatercept
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg sotatercept
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: High transfusion burden
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Low transfusion burden
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Sotatercept (all doses)
Number of subjects: 74
Study: 27636206

Group type: EXPERIMENTAL
Intervention: HMW carbohydrate solution (1.2 g•kg•bw‐1 of 10%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LMW carbohydrate solution (1.2 g•kg•bw‐1 of 10%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HMW vs LMW carbohydrate solutions
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both HMW and LMW carbohydrate solutions
Number of subjects: 16
Study: 24431912

Group type: EXPERIMENTAL
Intervention: Intermediate length adult-colonoscope
Number of subjects: 507

Group type: COMPARATOR
Intervention: Long length adult-colonoscope
Number of subjects: 507
Study: 22335889

Group type: EXPERIMENTAL
Intervention: Short-term psychotherapy (solution-focused or psychodynamic therapy, combined)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Long-term psychotherapy (psychodynamic)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Short-term therapy
Number of subjects: 326
Study: 20594096

Group type: EXPERIMENTAL
Intervention: Web‐based, stage‐tailored folic acid intervention
Number of subjects: 408

Group type: COMPARATOR
Intervention: Non‐stage‐tailored education (traditional brochure)
Number of subjects: 408
Study: 18774000

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 16314604

Group type: EXPERIMENTAL
Intervention: Paroxetine (up to 50 mg/day for 31 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 120
Study: 12074418

Group type: EXPERIMENTAL
Intervention: Sevoflurane and fentanyl
Number of subjects: 59

Group type: COMPARATOR
Intervention: Dehydrobenzperidol and fentanyl
Number of subjects: 59
Study: 9923503

Group type: EXPERIMENTAL
Intervention: Exam group (students participating in a major medical exam)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (students not participating in any exam)
Number of subjects: 26
Study: 7594100

Group type: EXPERIMENTAL
Intervention: Reteplase
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 1398
Study: 2315355

Group type: EXPERIMENTAL
Intervention: Tryptophan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 7431552

Group type: EXPERIMENTAL
Intervention: Erythromycin ophthalmic ointment
Number of subjects: 559

Group type: COMPARATOR
Intervention: Silver nitrate drops
Number of subjects: 559
Study: 6871773

Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg administered 30 minutes preoperatively
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg administered one hour preoperatively
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Zomepirac 200 mg administered one hour preoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standardized general anaesthetic without narcotic supplementation)
Number of subjects: 60
Study: 30831049

Group type: EXPERIMENTAL
Intervention: Songwriting intervention (group-based blues songwriting protocol)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control condition (questionnaire before intervention)
Number of subjects: 118
Study: 29129608

Group type: EXPERIMENTAL
Intervention: Preoperative progressive resistance training (PRT)
Number of subjects: 30
Study: 27513901

Group type: EXPERIMENTAL
Intervention: PGA monotherapy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: PGA combination regimens
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-PGA medications
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control subjects (not on any topical medications)
Number of subjects: 70
Study: 24962242

Group type: EXPERIMENTAL
Intervention: PGB-CR 330 mg
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: PGB-CR 165 mg
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study: 22841694

Group type: EXPERIMENTAL
Intervention: Food disgust
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-food disgust
Number of subjects: 0

Group type: COMPARATOR
Intervention: Food control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative emotion control
Number of subjects: 0
Study: 20569107

Group type: EXPERIMENTAL
Intervention: Tailored feedback report, telephone counseling, and supplementary educational materials focused on smoking cessation and improved nutrition
Number of subjects: 0
Study: 17697846

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16043801

Group type: EXPERIMENTAL
Intervention: 2 g/d ethyl‐EPA
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 12138321

Group type: EXPERIMENTAL
Intervention: Padma Lax
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 10457698

Group type: EXPERIMENTAL
Intervention: Office-based vision therapy with supplementary home therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Home therapy only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 7788822

Group type: EXPERIMENTAL
Intervention: 70% N2O/30% O2/halothane
Number of subjects: 320

Group type: COMPARATOR
Intervention: 100% O2/halothane
Number of subjects: 320
Study: 2193628

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 34185

Group type: EXPERIMENTAL
Intervention: Propranolol (daily doses increasing up to 3 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (mean therapeutic level of 1600 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol (dose increase related to hypertensive encephalopathy)
Number of subjects: 10
Study: 31354946

Group type: EXPERIMENTAL
Intervention: Auditory spatial training (15 sessions)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no auditory spatial training)
Number of subjects: 120
Study: 28462609

Group type: EXPERIMENTAL
Intervention: Single pair of gloves
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Double pair of gloves
Number of subjects: 41

Group type: COMPARATOR
Intervention: No gloves
Number of subjects: 41
Study: 26819451

Group type: EXPERIMENTAL
Intervention: Lymphopanel sequencing
Number of subjects: 215

Group type: COMPARATOR
Intervention: R-CHOP treatment in ABC patients
Number of subjects: 215
Study: 24332997

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate 325mg daily for 6 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23067321

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily for 12 weeks
Number of subjects: 151
Study: 19774310

Group type: EXPERIMENTAL
Intervention: 20-session pool exercise
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (60% participation)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (long-term follow-up)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 20-session pool exercise (subgroup analysis)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (6-session education programme)
Number of subjects: 166
Study: 17504996

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 1231

Group type: COMPARATOR
Intervention: Nonirradiated tumors
Number of subjects: 1231
Study: 15202823

Group type: EXPERIMENTAL
Intervention: Pulsatile roller pump perfusion using Sarns 8000 roller pump
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-pulsatile perfusion
Number of subjects: 40
Study: 11530128

Group type: COMPARATOR
Intervention: Estradiol (2 mg continuously during four 28-day cycles) + Medroxyprogesterone acetate (10 mg), Norethindrone acetate (1 mg), or Placebo (last 14 days of each cycle)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg continuously during four 28-day cycles) + Medroxyprogesterone acetate (10 mg), Norethindrone acetate (1 mg)
Number of subjects: 23
Study: 15481766

Group type: EXPERIMENTAL
Intervention: E + C (ephedrine 20 mg and caffeine 200 mg) in hypertensive patients treated with antihypertensive agents other than beta-blockers
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: E + C in normotensive patients
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo in hypertensive patients under any antihypertensive treatment
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo in normotensive patients
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: E + C in all groups
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo in all groups
Number of subjects: 136
Study: 8302451

Group type: EXPERIMENTAL
Intervention: Intravenous sodium naproxen (550 mg) immediately after induction of anesthesia (Group I)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intravenous sodium naproxen (550 mg) at the end of surgery (Group II)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intravenous normal saline immediately after induction of anesthesia (Group III)
Number of subjects: 75
Study: 3327697

Group type: EXPERIMENTAL
Intervention: Intravenous nifedipine infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous nifedipine infusion with additional propranolol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31436631

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the occipital cortex
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over the cerebellar vermis
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 26